Last reviewed · How we verify
Nitroglycerin tablets
At a glance
| Generic name | Nitroglycerin tablets |
|---|---|
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease (PHASE1)
- Metoprolol and Trimetazidine for Coronary Heart Disease With Angina (NA)
- The Effect of CPC on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope (PHASE2)
- Preoperative Sildenafil Administration for Hepatectomy (NA)
- Esophageal Food Impaction (PHASE4)
- Phosphate Lowering in CKD Trial (PHASE4)
- Letrozole as a Prophylaxis From GTN for Complete Mole Patients (PHASE2, PHASE3)
- Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: